About NeuroView Technology
NeuroView Technology is a private company based in Englewood, New Jersey. It has reported $554,491 raised in two offerings on Form D since June 2018. Its chief executive is James Karwel.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 13, 2023 | Dec 20, 2023 | $250,002of $4.8M target | 1 | $250K | EquityRule 506(b) | Form D ↗ |
| Jun 14, 2018 | Jun 29, 2018 | $304,489of $5.0M target | 6 | $50,748 | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $554,491 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NeuroView Technology's Form D filed Dec 20, 2023.
JK
James Karwel
Chief Executive Officer and director
LR
Louis Rauchenberger
Director
WD
Werner Doyle, M.D.
Director
RD
Ruben Kuzniecky, M.D.
Executive officer and director
SD
Steve Pacia, M.D.
Director
Earlier filings also listed Mark Goldstone (director, last listed Jun 2018).